Evidence map›Paper›PMID 34956313›Full record

ArticleFrontiers in genetics2021

A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer.

Chunmei Zhu, Shuyuan Zhang, Di Liu, Qingqing Wang, Ningning Yang, Zhewen Zheng, Qiuji Wu, Yunfeng Zhou

Abstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. PCMT1 as a prognostic marker in breast cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Methods in DNA methylation array dataset analysis: A review.Computational and structural biotechnology journal · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chunmei ZhuDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Shuyuan ZhangDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Di LiuDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Qingqing WangDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Ningning YangDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhewen ZhengDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Qiuji WuDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yunfeng ZhouDepartment of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerDNA methylationgene expressionprognostic signaturethe cancer genome atlas (TCGA)

Identifiers

PMID34956313
PMCPMC8693898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.